Reimagining commercial in life sciences

Microsegmentation and predictive models combined with intelligent business rules can support scalable omnichannel engagement. Take a look at how Deloitte’s Next Best Engagement solution is helping health care companies take control of “sense and respond” engagement with a focus on driving improved experiences and delivering incremental sales.

Deliver a competitive advantage to marketing. Learn how Deloitte’s IntelliDoc™ leverages data analytics and AI to deliver insights and significantly reduce total document review time, speeding up the ways you interact with your customers and optimizing content spend.

ConvergeHEALTH Connect (CHC) for Life Sciences is an industry-leading, high-touch digital solution built on Salesforce Health Cloud. This digital patient experience platform empowers companies to directly manage and deliver personalized patient engagement and support services across global markets, communication channels, and the full treatment ecosystem, improving adherence, care coordination, and outcomes. Explore how Deloitte delivers consistent, high-touch patient engagement and support across the full treatment ecosystem.

Life sciences companies need to transform their commercial models across marketing, sales, and market access. But how are you using AI to drive this transformation? And how are you using data and insights to drive ROI across marketing, sales, and market access? Take a closer look at how ConvergeHEALTH CognitiveSpark™ for Commercial leverages AI to boost marketing, sales, and market access and improve pharma ROI.

Life sciences manufacturers—from those that develop small molecule products to complex biologics to cell and gene therapies—often face challenges developing successful market access strategies. Payers’ growing influence, declining access to physicians, intense competition, and a shift away from primary care drugs toward specialty therapy areas are leading to a constrained access landscape. Find out how Deloitte’s Market Access Excellence (MAx) Framework can help cross-functional brand teams align on the strategic choices needed to enhance patient access throughout the product life cycle.

Pharmaceutical pricing has become increasingly complex, and state regulations often further complicate this landscape. How can companies improve market access and reimbursement strategies for greater transparency—and improved patient outcomes? Through the data science-driven, integrated platform of ConvergeHEALTH Miner™ Access.